SHZ · 002880.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shenzhen Weiguang Biological Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shenzhen Weiguang Biological Products Co., Ltd.’s forward annual dividend is CN¥0.20 per share, paid annual. The forward yield is 1.01% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Shenzhen Weiguang Biological Products Co., Ltd.’s next earnings report is currently expected on Apr 28, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shenzhen Weiguang Biological Products Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shenzhen Weiguang Biological Products Co., Ltd. is a Chinese enterprise primarily dedicated to the entire lifecycle of blood products, encompassing their research, development, manufacturing, and distribution within the domestic market. Its comprehensive portfolio features a range of crucial blood-derived therapies, including human albumin, various intravenous immunoglobulin preparations (such as pH4 and its freeze-dried counterpart), general human immunoglobulin, and specific immunoglobulins targeting conditions like hepatitis B, rabies, and tetanus. Additionally, it provides histamine human immunoglobulin and human fibrinogen. These offerings collectively represent nine distinct product types, available in twenty-one different specifications. Established in 1985, the firm maintains its headquarters in Shenzhen, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥349.09M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥56.74+CN¥2.52 (+4.65%)
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.74% below the high.
CN¥7.02+CN¥0.24 (+3.54%)
Jinghua Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.49% below the high.
CN¥26.88+CN¥0.66 (+2.52%)
Jiangsu Jibeier Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.06% below the high.
CN¥4.81+CN¥0.12 (+2.56%)
Shanghai Kaibao Pharmaceutical CO.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.8% below the high.
CN¥4.09+CN¥0.10 (+2.51%)
Luoxin Pharmaceuticals Group Stock Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.55% below the high.
CN¥26.58+CN¥0.32 (+1.22%)
Jianmin Pharmaceutical Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.85% below the high.
CN¥7.95+CN¥0.30 (+3.92%)
Beijing Science Sun Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.39% below the high.
CN¥12.72+CN¥0.17 (+1.35%)
Tianjin Lisheng Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.49% below the high.
